ライフサイエンスコーパス: restrictive cardiomyopathy

1 in systolic and diastolic diameter (akin to 'restrictive cardiomyopathy').

2 nts with known constrictive pericarditis and restrictive cardiomyopathy.

3 ing comparable to that observed during human restrictive cardiomyopathy.

4 the 58 children with mixed hypertrophic and restrictive cardiomyopathy.

5 sm or with mixed hypertrophic and dilated or restrictive cardiomyopathy.

6 sease should be ongoing in all patients with restrictive cardiomyopathy.

7 TnI) mutation R145W has been associated with restrictive cardiomyopathy.

8 or which mutations have been associated with restrictive cardiomyopathy.

9 icit and possibly reduced cardiac output and restrictive cardiomyopathy.

10 ic pattern of impaired diastolic filling and restrictive cardiomyopathy.

11 differentiate constrictive pericarditis from restrictive cardiomyopathy.

12 cities are markedly reduced in patients with restrictive cardiomyopathy.

13 fferentiating constrictive pericarditis from restrictive cardiomyopathy.

14 fferentiating constrictive pericarditis from restrictive cardiomyopathy.

15 y diagnosed with dilated, arrhythmogenic, or restrictive cardiomyopathies.

16 udden cardiac death is common in humans with restrictive cardiomyopathies and long QT syndromes.

17 ilial amyloidosis (11), hemochromatosis (1), restrictive cardiomyopathy and cardiac cirrhosis (1), pr

18 nction between constrictive pericarditis and restrictive cardiomyopathy and may prove to be valuable

19 eak early diastolic velocity is blunted with restrictive cardiomyopathy and preserved with constricti

20 r hypertrophic cardiomyopathy (HCM), 12% for restrictive cardiomyopathy, and 23% for left ventricular

21 tions within this region are associated with restrictive cardiomyopathy, and C-terminal deletion of c

22 The restrictive cardiomyopathies are a heterogenous group of

23 Pediatric patients with restrictive cardiomyopathy are at risk for acute high-gr

24 although other forms of cardiomyopathy (ie, restrictive cardiomyopathy, arrhythmogenic right ventric

25 on, force transmission disease; hypertrophic-restrictive cardiomyopathies as sarcomeric, force genera

26 Pediatric restrictive cardiomyopathy carries a poor prognosis seco

27 trospective study of pediatric patients with restrictive cardiomyopathy diagnosed between April 1994

28 t proline to leucine (P838L) caused dominant restrictive cardiomyopathy in a pediatric patient.

29 Idiopathic restrictive cardiomyopathy is a poorly recognized entity

30 al echocardiographic criteria for idiopathic restrictive cardiomyopathy, mainly dilated atria with no

31 Consistent with the pathophysiology, the restrictive cardiomyopathy mutation, troponin I R192H, a

32 nt number of suspected HFpEF patients have a restrictive cardiomyopathy or chronic pericardial diseas

33 Idiopathic restrictive cardiomyopathy or nondilated, nonhypertrophi

34 ological factors responsible for causing the restrictive cardiomyopathy phenotype in some of the gene

35 LNC variants among patients with dilated and restrictive cardiomyopathies, pointed to this gene as an

36 The differential diagnosis between restrictive cardiomyopathy (RCM) and constrictive perica

37 Restrictive cardiomyopathy (RCM) has been associated wit

38 ation of constrictive pericarditis (CP) from restrictive cardiomyopathy (RCM) is a complex and often

39 Inherited restrictive cardiomyopathy (RCM) is a debilitating disea

40 Restrictive cardiomyopathy (RCM) is a rare cardiomyopath

41 Restrictive cardiomyopathy (RCM) is a rare disorder char

42 Restrictive cardiomyopathy (RCM) is an uncommon heart mu

43 Restrictive cardiomyopathy (RCM) is characterized by non

44 Restrictive cardiomyopathy (RCM) is rare in children, an

45 use hypertrophic (HCM), dilated (DCM) and/or restrictive cardiomyopathy (RCM), but disease-causing me

46 anics of constrictive pericarditis (CP) with restrictive cardiomyopathy (RCM), or healthy controls; t

47 n I (cTnI) R145W mutation is associated with restrictive cardiomyopathy (RCM).

48 g chronic constrictive pericarditis (CP) and restrictive cardiomyopathy (RCM).

49 thy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM).

50 rentiate constrictive pericarditis (CP) from restrictive cardiomyopathy (RCMP).

51 on that is seen in patients suffering from a restrictive cardiomyopathy that is associated with the c

52 Restrictive cardiomyopathy was suggested by reduced aver

53 Heart failure associated with unexplained restrictive cardiomyopathy was the most common clinical

54 5W, A171T, K178E, and R192H) associated with restrictive cardiomyopathy were distinguishable from hyp

55 s with constrictive pericarditis and 44 with restrictive cardiomyopathy were used for developing an a

56 rther activation of PKCalpha caused a lethal restrictive cardiomyopathy with marked interstitial fibr